https://www.bioworld.com/rss en-us http://www.bioworld.com/articles/730284 Mon, 13 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730284-stryker-agrees-to-buy-amplitude-vascular-systems-for-ivl-tech Pulse IVL intravascular lithotripsy (IVL) platform Pulse IVL intravascular lithotripsy platform. Credit: Amplitude Vascular Systems Inc. http://www.bioworld.com/articles/730283 Mon, 13 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730283-biopharma-deal-value-gains-17-in-early-2026 Gold wireframe handshake http://www.bioworld.com/articles/730282 Mon, 13 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730282-regeneron-enters-radiopharma-space-via-telix-deal Open blue capsule with yellow radioactive symbol http://www.bioworld.com/articles/730279 Mon, 13 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730279-revenio-speeds-up-growth-acquiring-visionix-for-290m Close up of eye and vision test http://www.bioworld.com/articles/730326 Mon, 13 Apr 2026 09:00:00 -0400 https://www.bioworld.com/articles/730326-abbvie-licenses-ex-china-rights-to-haisco-pain-compounds 3D illustration of a nerve cell http://www.bioworld.com/articles/730212 Thu, 09 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730212-everest-to-acquire-singapore-unit-of-hasten-bio-in-250m-deal Handshake behind digital globe http://www.bioworld.com/articles/730207 Thu, 09 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730207-c4-yourself-1b-second-roche-deal-evidence-of-dac-faith Antibody-drug conjugate http://www.bioworld.com/articles/730133 Tue, 07 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730133-gilead-buying-tubulis-and-its-adcs-in-5b-takeover-bid Antibody-drug conjugates floating on light purple background http://www.bioworld.com/articles/730115 Mon, 06 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730115-vykat-caveat-neurocrines-29b-soleno-bid-low-ball Vykat XR Credit: Soleno Therapeutics Inc. http://www.bioworld.com/articles/730075 Thu, 02 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730075-blockbuster-deals-push-med-tech-m-and-a-above-40b-in-q1-2026 M&A cityscape http://www.bioworld.com/articles/730126 Thu, 02 Apr 2026 09:00:00 -0400 https://www.bioworld.com/articles/730126-korsana-boosts-alzheimers-work-with-reverse-merger-380m-financing Connecting puzzle pieces http://www.bioworld.com/articles/729977 Wed, 01 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/729977-korsana-boosts-alzheimers-work-with-reverse-merger-380m-financing Connecting puzzle pieces http://www.bioworld.com/articles/730091 Tue, 31 Mar 2026 12:00:00 -0400 https://www.bioworld.com/articles/730091-lilly-taps-insilico-ai-in-275b-deal-to-expand-pipeline-options Pill in immersive interface http://www.bioworld.com/articles/730090 Tue, 31 Mar 2026 12:00:00 -0400 https://www.bioworld.com/articles/730090-otsuka-to-acquire-ptsd-drugmaker-transcend-in-12b-deal Brain with handshake and cityscape http://www.bioworld.com/articles/729964 Tue, 31 Mar 2026 12:00:00 -0400 https://www.bioworld.com/articles/729964-galapagos-enters-new-era-as-lakefront-after-reshaping-gilead-alliance Handshake icon engraved on metal hexagonal background http://www.bioworld.com/articles/729963 Tue, 31 Mar 2026 12:00:00 -0400 https://www.bioworld.com/articles/729963-highly-complementary-biogen-pays-56b-whos-jealous-of-apellis Handshake with charts, maps, data http://www.bioworld.com/articles/729962 Tue, 31 Mar 2026 12:00:00 -0400 https://www.bioworld.com/articles/729962-lilly-shifts-from-obesity-to-narcolepsy-with-78b-centessa-buy Brain with clock hands, day and night background http://www.bioworld.com/articles/729952 Mon, 30 Mar 2026 12:00:00 -0400 https://www.bioworld.com/articles/729952-otsuka-to-acquire-ptsd-drugmaker-transcend-in-12b-deal Brain with handshake and cityscape http://www.bioworld.com/articles/729949 Mon, 30 Mar 2026 12:00:00 -0400 https://www.bioworld.com/articles/729949-lilly-taps-insilico-ai-in-275b-deal-to-expand-pipeline-options Pill in immersive interface http://www.bioworld.com/articles/729915 Fri, 27 Mar 2026 08:00:00 -0400 https://www.bioworld.com/articles/729915-novartis-buying-allergy-firm-excellergy-for-2b Handshake dollar sign http://www.bioworld.com/articles/729837 Wed, 25 Mar 2026 12:00:00 -0400 https://www.bioworld.com/articles/729837-merck-adds-terns-promising-cml-drug-in-67b-buyout Acquisition target http://www.bioworld.com/articles/729830 Tue, 24 Mar 2026 12:00:00 -0400 https://www.bioworld.com/articles/729830-chinas-pharma-rise-rattles-us-policymakers China and U.S. flags http://www.bioworld.com/articles/729829 Tue, 24 Mar 2026 12:00:00 -0400 https://www.bioworld.com/articles/729829-gilead-pens-dual-purpose-2b-ouro-m-and-a-deal-with-galapagos Hands holding gears http://www.bioworld.com/articles/729826 Tue, 24 Mar 2026 12:00:00 -0400 https://www.bioworld.com/articles/729826-with-improved-technologies-biomarkers-failed-drugs-may-come-into-their-own Vials, syringes, and pills http://www.bioworld.com/articles/729823 Tue, 24 Mar 2026 12:00:00 -0400 https://www.bioworld.com/articles/729823-somatic-genomics-pioneer-quotient-signs-22b-ibd-deal-with-merck Gastrointestinal system with DNA, scientific background http://www.bioworld.com/articles/729814 Mon, 23 Mar 2026 12:00:00 -0400 https://www.bioworld.com/articles/729814-looking-for-tip-of-the-spear-science-via-m-and-as-investments Gold chain link engraved with "partnership" http://www.bioworld.com/articles/729810 Mon, 23 Mar 2026 12:00:00 -0400 https://www.bioworld.com/articles/729810-kali-signs-12b-sanofi-deal-for-autoimmune-asset-kt-501 Concept of business partnership http://www.bioworld.com/articles/729791 Mon, 23 Mar 2026 09:00:00 -0400 https://www.bioworld.com/articles/729791-kyorin-licenses-ube-drug-candidates Illustration of pill being analyzed http://www.bioworld.com/articles/729757 Fri, 20 Mar 2026 12:00:00 -0400 https://www.bioworld.com/articles/729757-azstarys-re-born-with-collegiums-adhd-buy Tangled lines above silhouette http://www.bioworld.com/articles/729756 Fri, 20 Mar 2026 12:00:00 -0400 https://www.bioworld.com/articles/729756-synnovations-pi3k-inhibitor-portfolio-draws-novartis-in-3b-deal Novartis campus in Basel, Switzerland Credit: Novartis AG